Skip to main content
Royal Philips closes $2.2B deal to buy Spectranetics

The $2.2 billion acquisition of Spectranetics was completed by Royal Philips, making Spectranetics a part of its Image-Guided Therapy Business Group. Spectranetics makes a drug-coated angioplasty balloon, a medical laser and catheters for treating patients with blockages in leg and coronary arteries, as well as to remove infected pacemaker leads.

Full Story: